Molecular marker for auxiliary diagnosis of tubercular meningitis as well as application and kit thereof
A technology of tuberculous meningitis and molecular markers, which is applied in the field of disease diagnosis, can solve problems such as the inability to detect cerebrospinal fluid samples, and improve the effect of diagnosis
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0033] In order to identify differential miRNAs for distinguishing tuberculous meningitis from other infectious meningitis, 11 patients with tuberculous meningitis and 12 patients with other infectious meningitis (including 7 patients with viral meningitis, 3 Genome-wide miRNA microarray analysis was performed on the cerebrospinal fluid of 1 patient with bacterial meningitis and 2 patients with cryptococcal meningitis, and then the original sample data was standardized to obtain the fold difference value (Fold Change), with Fold Change>1.5 and P< 0.05 screened out 7 differential miRNAs between the two groups. The results are shown in Table 1.
[0034] TBM (tuberculous meningitis) group: (1) The symptoms and signs of meningitis in patients include one or more of the following: headache, irritability, vomiting, fever, neck stiffness, convulsions, focal neurological dysfunction, altered consciousness or drowsiness. (2) Positive acid-fast staining of cerebrospinal fluid, or posi...
Embodiment 2
[0039] Real-time fluorescent quantitative PCR (qRT-PCR) to verify differential miRNA
[0040](1) Reagents: miRNA chip: Agilent human miRNA chip (8*60K) V21 chip; internal reference gene for qPCR: Cel-miR-39; reagents for RNA extraction, reverse transcription and qPCR detection are commercial reagents (QIAGEN).
[0041] (2) Internal reference gene for qPCR: Cel-miR-39. Internal reference and target primers: See the table below for the upstream primers, and the downstream primers are universal primers (downstream primer sequence: 5'-CTCAACTGGTGTCGTGGA-3')
[0042] miRNA upstream primer Cel-miR-39 5'-GCCGAGAGCTGATTTCGTCT-3' hsa-miR-21-5p 5'-GCCGAGTAGCTTTATCAGACTG-3' hsa-miR-1587 5'-TCGGCAGGTTGGGCTGGGCT-3' hsa-miR-3152-3p 5'-GCCGAGTGTGTTAGAATAGGG-3' hsa-miR-7975 5'-TCGGCAGGATCCTAGTCAC-3'
[0043] (3) Instrument: ABI Quantistudio7.
[0044] The results are shown in Table 2 and Table 3.
[0045] Table 2. qPCR detection raw data (...
Embodiment 3
[0050] The inventors tried to combine differentially expressed miRNAs to improve specificity and sensitivity.
[0051] Table 3. qPCR detection miRNA combination (predicted probability)
[0052]
[0053]
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com